IONIS PHARMACEUT reported $283.45M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Arrowhead Research ARWR:US USD 138.85M 10.64M
Astellas Pharma 4503:JP JPY 761.41B 20.87B
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Esperion Therapeutics ESPR:US USD 82.34M 70K
Exelixis EXEL:US USD 301.73M 2.79M
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Moderna Inc MRNA:US USD 6.81B 5M
Nektar Therapeutics NKTR:US USD 83.99M 21M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Novartis NOVN:VX USD 28.16B 514M
Omeros OMER:US USD 39.51M 1.01M
Ptc Therapeutics PTCT:US USD 420.08M 147.29M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Roche Holding ROG:VX 27.41B 11.01B
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M